Skip to contentW
Whitehawk Therapeutics, Inc.
W
WHWKWhitehawk Therapeutics, Inc. Released Nov 13, 2017, before the open
10-Q filed Nov 13, 2017, 44 days after period end · 0001564590-17-023441
Q3 2017 · 10-Q
Revenue—
Net Income-$4.65M-$4.65MN/M vs Q3 2016N/M vs Q2 2017 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
-$0.17-$0.17
N/M vs Q2 2017
Operating Income-$4,756,238N/M Operating Cash Flowderived-$4,019,027N/M Free Cash Flowderived-$4,019,027N/M Filing lag
ended Sep 30, 2017 · filed Nov 13, 2017 · 44 d after period end